By Galen Care Partners on Wednesday, 26 July 2017
Category: Galen Care Partners News

Short-term Interleukin Inhibition Ineffective in CKD-MBD

Serum phosphorus and intact parathyroid hormone levels were not reduced with 12 weeks of rilonacept therapy.
Original link
Leave Comments